Bristol Myers Buys Nvidia's Latest AI Computing System for Drug Research
The drugmaker said the system will expand AI work across its research unit and help screen dozens of drug candidates earlier in development.
- On Monday in NEW YORK, Bristol Myers Squibb announced it is purchasing the latest-generation Nvidia Vera Rubin computing system, becoming the first life sciences company to acquire an Nvidia DGX SuperPOD based on the new architecture.
- Greg Meyers, the company's chief digital and technology officer, said the investment addresses rapidly growing computing demands as Bristol deploys larger AI-enabled models across its research organization.
- The new system offers improved energy efficiency; "Think of it as 10 times more compute capacity per watt spent," Meyers said, noting that Electricity is not getting cheaper.
- Robert Plenge, chief research officer at Bristol Myers, said the capabilities allow the company to cycle through many more potential drug candidates, cutting development time by 20 per cent to 30 per cent.
- Gains in development time could reach 50 per cent in coming years, Plenge said, as this investment builds on a smaller SuperPOD system the drugmaker previously bought from Nvidia, which is now two or three generations behind Vera Rubin.
14 Articles
14 Articles
Channel News Asia
Bristol Myers buys Nvidia's latest AI computing system for drug research
NEW YORK, July 20 : Bristol Myers Squibb said on Monday it is buying the latest-generation computing system from chip company Nvidia to support its use of artificial intelligence across its drug discovery and development operations.The drugmaker said it will be the first life sciences company to buy an Nvidia
Pharma group BMS doubles down on AI for research
After experiencing and demonstrating how AI can transform drug discovery, pharmaceutical company Bristol Myers Squibb (BMS) is deploying its second Nvidia DGX SuperPOD, built on eight DGX Vera Rubin NVL772 systems – the most powerful and energy-efficient AI cluster in life sciences. “Instead of equipping a small group of researchers with access to the supercomputer, we’re opening it up to literally every scientist,” says Erin Davis, vice-preside…
Coverage Details
Bias Distribution
- 63% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
